Anatara Lifesciences Limited (ASX:ANR) Annual Report 2020



The latest annual report of Anatara Lifesciences Limited (ANR) was published on 30 Jun 2020. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - ANR Annual Results

Amounts in AUD

Total Revenue
-
Gross Profit
-1.29M
EBIT
-3.52M
Net Tangible Assets
2.86M
Net Income
-3.36M
Capital Expenditures
-4.08k

ANR Income Statement 2020 Annual Report

As per the latest Income Statement of ANR, the Net revenue increased by $NaN (NaN%) compared to the previous period. The operating income in 2020 decreased by $-507700 (-17%). The net income as per the annual report was -3.36M which decreased by $-496372 (-17%) compared to previous year.

Income Statement Report (2020/2019)

20202019
Total Revenue-663.4k
Gross Profit-1.29M-112.85k
Operating Income-3.52M-3.01M
Income Before Tax-3.36M-2.87M
Net Income-3.36M-2.87M

Balance Sheet - ANR 2020 Annual Report

Read further: ANR Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Anatara Lifesciences Limited showed the company increased the cash on balance sheet by $1.32M (97%). The Net tangible assets of ANR on the balance sheet were at 2.86M which is $-3.05M (-52%) less than previous annual report. The total stockholder equity also decreased by $-3.06M (-52%) compared to previous reporting period.

Balance Sheet Statement Report (2020/2019)

20202019
Cash2.68M1.36M
Total Assets3.34M 6.38M
Long Term Debt--
Total Liabilities486.96k 466.76k
Total Shareholder Equity2.86M5.92M
Net Tangible Assets2.86M5.91M

Cash Flow Statement - ANR 2020 Annual Report

The 2020 annual cash flow statement of Anatara Lifesciences Limited showed that the net income decreased by $-496372 (-17%) compared to previous reporting period. Also the capital expenditure of ANR increased by $0 (0%).

As of 2020, the total cash from investing activities was 4.05M and total cash from financing activities was -.

Cash Flow Statement Report (2020/2019)

20202019
Net Income-3.36M-2.87M
Capital Expenditures-4.08k-4.08k
Dividends Paid--
Total Cash From From Investing Activities4.05M2.15M
Total Cash From From Financing Activities--

Anatara Lifesciences Limited Annual Report History

Income Statement

Income Statement history of Anatara Lifesciences Limited (ASX:ANR)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Total Revenue-663.4k6.47k2.85M
Cost Of Revenue1.29M776.26k785.93k1.26M
Gross Profit-1.29M-112.85k-779.46k1.59M
Research Development----
Selling General Administrative2.92M3.78M4.35M3.27M
Non Recurring----
Other Operating Expenses-687.45k-877.57k-1.34M227.2k
Total Operating Expenses3.52M3.67M3.8M4.78M
Operating Income-3.52M-3.01M-3.79M-1.92M
Total Other Income Expense Net153.83k142.5k220.35k217.75k
Ebit-3.52M-3.01M-3.79M-1.92M
Interest Expense----
Income Before Tax-3.36M-2.87M-3.57M-1.71M
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-3.36M-2.87M-3.57M-1.71M
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income-3.36M-2.87M-3.57M-1.71M
Net Income Applicable To Common Shares-3.36M-2.87M-3.57M-1.71M

Balance Sheet Statement

Balance Sheet Statement history of Anatara Lifesciences Limited (ASX:ANR)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Cash2.68M1.36M1.45M8.77M
Net Receivables630.33k895.99k2.04M1.33M
Other Current Assets23.74k49.02k74.46k83.93k
Total Current Assets3.34M6.36M9.76M12.28M
Property Plant Equipment7.19k20.2k42.92k40.93k
Total Assets3.34M6.38M9.81M12.32M
Accounts Payable33.86k116.76k80.66k44.73k
Other Current Liab26.62k33.17k95.13k-
Other Liab22.93k13.94k638.56k-
Total Current Liabilities464.03k452.82k586.4k295.44k
Total Liab486.96k466.76k1.22M295.44k
Common Stock17.04M16.94M16.94M16.94M
Retained Earnings-14.74M-11.52M-8.94M-5.37M
Treasury Stock553.34k499.07k583.75k448.42k
Other Stockholder Equity553.34k499.07k583.75k448.42k
Total Stockholder Equity2.86M5.92M8.59M12.02M
Net Tangible Assets2.86M5.91M8.58M12.02M
Long Term Debt----

Cash Flow Statement

Cash Flow Statement history of Anatara Lifesciences Limited (ASX:ANR)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Net Income-3.36M-2.87M-3.57M-1.71M
Depreciation16.1k22.73k21.18k16.94k
Change To Netincome305.46k196.39k-83.85k250.8k
Change To Account Receivables265.65k1.14M-615.39k-1.05M
Change To Liabilities47.8k-54.96k885.12k-406.58k
Change To Operating Activities4.73k-677.8k46.81k15.87k
Total Cash From Operating Activities-2.72M-2.24M-3.32M-2.88M
Capital Expenditures-4.08k-4.08k-23.17k-41.61k
Investments4.05M2.15M-4.2M5.3M
Total Cashflows From Investing Activities4.05M2.15M-4M5.26M
Change In Cash1.32M-87.66k-7.32M2.38M
Dividends Paid----
Total Cash From Financing Activities----